Navigation Links
Fulgent Therapeutics Announces That CAP (College of American Pathologists) Has Accredited Their Clinical Laboratory
Date:10/24/2013

Temple City, CA (PRWEB) October 24, 2013

Fulgent Therapeutics, a CLIA Certified Laboratory, is proud to announce accreditation by the College of American Pathologists (CAP). CAP’s Laboratory Accreditation Program is recognized by the United States government as being equal-to or more-stringent-than the government’s own inspection program. With this accreditation, Fulgent's Diagnostic Lab is a part of an internationally recognized group of facilities that meet the highest standards of excellence and best practices in laboratory operations.    

The CAP accreditation process was comprised of CAP inspectors that examined Fulgent’s laboratory procedure, quality control, safety program, staff qualifications, equipment, facilities, and overall management and laboratory records.

Fulgent Therapeutics has recently announced a wide range of diagnostic panels for a variety of inherited diseases, including cardiology, pediatrics, and neurology as well as inherited cancer predisposition.

Additional information: info(at)fulgent-therapeutics(dot)com or 626-350-0537 x106.

About Fulgent Therapeutics LLC: Fulgent’s diagnostic lab was CLIA approved in May 2012. Fulgent Diagnostics provides affordable next generation genetic tests using massively parallel processes to a global community. Tests range from hereditary cancers to esoteric diseases. For a complete list of tests available please visit: fulgent-therapeutics.com/testing.    

About the College of American Pathologists:

The College of American Pathologists (CAP) is a medical society that serves more than 18,000 physician members and the global laboratory community. It is the world’s largest association composed exclusively of board-certified pathologists and is the worldwide leader in laboratory quality assurance. The College advocates accountable, high-quality, and cost-effective patient care. More information about the CAP can be found at http://www.cap.org.

Fulgent Therapeutics LLC
4978 Santa Anita Ave, Ste. 205
Temple City, CA
91780

Read the full story at http://www.prweb.com/releases/2013/10/prweb11264218.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Fulgent Therapeutics Announces Their Comprehensive Hereditary Cancer Test Including BRCA1 and BRCA2 Analysis
2. Multiple Myeloma Therapeutics Future Discussed in In-demand MP Advisors Report Published at MarketPublishers.com
3. American Assoc. for Cancer Research co-hosts conference on molecular targets and cancer therapeutics
4. Global Dermatophytic Onychomycosis Therapeutics Market 2012 - 2016: Worldwide Industry Latest Market Share, Growth, Size, Trends, Strategy And Forecast Research Report
5. Global Huntington’s Disease Therapeutics Industry
6. Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
7. Mount Sinai Grants Exclusive License to Plexcera Therapeutics to Develop Treatments for Farber Disease and Cystic Fibrosis
8. Multiple Sclerosis Therapeutics Market to 2019 – Treatment Diversification and Pipeline Innovation to Drive Growth, Says a New Report at RnRMarketResearch.com
9. Refractory Hematological Malignancies (MDS, AML) Market Emerging Therapeutics Analysis Available at ReportsnReports.com
10. Pain Management Therapeutics Market Will Decline USD 29.47 Billion in 2018 : Transparency Market Research
11. Pain Management Therapeutics Market Will Decline USD 29.47 Billion in 2018 : Transparency Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping ... fitness app. The fitness app plans to fix the two major problems leading the fitness ... size fits all type program , They don’t eliminate all the reasons people ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
Breaking Medicine Technology: